Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models.
Lung cancer remains the leading cause of cancer deaths in the United States and the rest of the world. The advent of molecularly directed therapies holds promise for improvement in therapeutic efficacy. Cytosolic phospholipase A2 (cPLA2) is associated with tumor progression and radioresistance in mo...
Main Authors: | Dinesh Thotala, Jeffrey M Craft, Daniel J Ferraro, Rama P Kotipatruni, Sandeep R Bhave, Jerry J Jaboin, Dennis E Hallahan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3716600?pdf=render |
Similar Items
-
Autotaxin inhibition with PF8380 enhances the radiosensitivity of human and murine glioblastoma cell lines
by: Sandeep R Bhave, et al.
Published: (2013-09-01) -
GSK-3𝜷: A Bifunctional Role in Cell Death Pathways
by: Keith M. Jacobs, et al.
Published: (2012-01-01) -
The Preparation and Application of the Truncated Biotinylated Carboxylase Carrier protein(BCCP)-tagged Porcine Pancreatic PhospholipaseA2
by: Lejean Wei, et al.
Published: (1999) -
Cytosolic Phospholipase A2(cPLA2) Immunoreactivity Is Elevated in Alzheimer's Disease Brain
by: Diane T. Stephenson, et al.
Published: (1996-02-01) -
Highly Potent 2‑Oxoester Inhibitors of Cytosolic Phospholipase A2 (GIVA cPLA2)
by: Anastasia Psarra, et al.
Published: (2018-08-01)